Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of ...
Incorporating dynamic pricing into cost-effectiveness analysis could offer significant benefits for equity in health care. The life cycle of a drug encompasses phases of market exclusivity, ...
Neumora Therapeutics (NMRA) has been able to establish an advanced phase 3 program, which is ultimately going to be composed of several late-stage studies. This is going to be the inclusion of three ...